These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 14751759)

  • 1. Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9.
    Takeshita F; Gursel I; Ishii KJ; Suzuki K; Gursel M; Klinman DM
    Semin Immunol; 2004 Feb; 16(1):17-22. PubMed ID: 14751759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial CpG-DNA licenses TLR9.
    Bauer S; Wagner H
    Curr Top Microbiol Immunol; 2002; 270():145-54. PubMed ID: 12467249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways.
    Yasuda K; Yu P; Kirschning CJ; Schlatter B; Schmitz F; Heit A; Bauer S; Hochrein H; Wagner H
    J Immunol; 2005 May; 174(10):6129-36. PubMed ID: 15879108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides.
    Roberts TL; Sweet MJ; Hume DA; Stacey KJ
    J Immunol; 2005 Jan; 174(2):605-8. PubMed ID: 15634876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of TLR9 activation.
    Latz E; Visintin A; Espevik T; Golenbock DT
    J Endotoxin Res; 2004; 10(6):406-12. PubMed ID: 15588423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.
    Roda JM; Parihar R; Carson WE
    J Immunol; 2005 Aug; 175(3):1619-27. PubMed ID: 16034101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA.
    Nativel B; Ramin-Mangata S; Mevizou R; Figuester A; Andries J; Iwema T; Ikewaki N; Gasque P; Viranaïcken W
    Immunology; 2019 Oct; 158(2):85-93. PubMed ID: 31335975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.
    Bauer S; Kirschning CJ; Häcker H; Redecke V; Hausmann S; Akira S; Wagner H; Lipford GB
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9237-42. PubMed ID: 11470918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. For whom the bug tolls.
    Goldberg J
    Trends Microbiol; 2001 Mar; 9(3):109. PubMed ID: 11239775
    [No Abstract]   [Full Text] [Related]  

  • 11. Toll-like receptor 9, CpG DNA and innate immunity.
    Ashkar AA; Rosenthal KL
    Curr Mol Med; 2002 Sep; 2(6):545-56. PubMed ID: 12243247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
    Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Toll-like receptor recognizes bacterial DNA.
    Hemmi H; Takeuchi O; Kawai T; Kaisho T; Sato S; Sanjo H; Matsumoto M; Hoshino K; Wagner H; Takeda K; Akira S
    Nature; 2000 Dec; 408(6813):740-5. PubMed ID: 11130078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
    Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
    Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets.
    Hemmi H; Kaisho T; Takeda K; Akira S
    J Immunol; 2003 Mar; 170(6):3059-64. PubMed ID: 12626561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential signaling by CpG DNA in DCs and B cells: not just TLR9.
    Verthelyi D; Zeuner RA
    Trends Immunol; 2003 Oct; 24(10):519-22. PubMed ID: 14552833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA motifs suppressing TLR9 responses.
    Trieu A; Roberts TL; Dunn JA; Sweet MJ; Stacey KJ
    Crit Rev Immunol; 2006; 26(6):527-44. PubMed ID: 17341193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG DNA in the prevention and treatment of infections.
    Dalpke A; Zimmermann S; Heeg K
    BioDrugs; 2002; 16(6):419-31. PubMed ID: 12463765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells.
    Takeshita F; Leifer CA; Gursel I; Ishii KJ; Takeshita S; Gursel M; Klinman DM
    J Immunol; 2001 Oct; 167(7):3555-8. PubMed ID: 11564765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling.
    Shimosato T; Kitazawa H; Katoh S; Tohno M; Iliev ID; Nagasawa C; Kimura T; Kawai Y; Saito T
    Biochem Biophys Res Commun; 2005 Jan; 326(4):782-7. PubMed ID: 15607737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.